4409 |
Selected New LAA Closure Techniques and Devices |
Horst Sievert |
Apr. 20. 23 |
4408 |
LAA Closure with WATCHMAN FLX |
Shunsuke Kubo |
Apr. 20. 23 |
4407 |
LAA Closure with AMULET and LAmbre Device |
Cheung Chi Simon Lam |
Apr. 20. 23 |
4406 |
Current Status and Future Perspectives of LAA Closure |
Min Soo Cho |
Apr. 20. 23 |
4405 |
Temporal Trends in TAVR Indication and Outcomes - Insights from the US TVT Registry |
David Joel Cohen |
Apr. 20. 23 |
4404 |
Hostile Femoral Access in Patients Undergoing TAVR: What¡¯s the Best Choice? |
Kentaro Hayashida |
Apr. 20. 23 |
4403 |
Neurocognitive Trajectory Following TAVR |
Mao-Shin Lin |
Apr. 20. 23 |
4402 |
ACURATE NEO 2 |
Young-Guk Ko |
Apr. 20. 23 |
4401 |
EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART) |
Eberhard Grube |
Apr. 20. 23 |
4400 |
SAPIEN: Simpler and More Sophisticated (X4 and ALLIANCE) |
Duk-Woo Park |
Apr. 20. 23 |